Why I’m Avoiding Vodafone Group plc & Stanley Gibbons Group PLC For 2016

G A Chester explains the challenges facing Vodafone Group plc (LON:VOD) and Stanley Gibbons Group PLC (LON:SGI).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Vodafone (LSE: VOD) and Stanley Gibbons (LSE: SGI) are two stocks I’m steering clear of for 2016. Let me explain why.

Vodafone

Vodafone’s financial year ending 31 March 2016 is expected to mark the low point for earnings as the FTSE 100 mobile giant’s Project Spring investment programme is completed with a capex splurge of £8.5bn to £9bn. For the year to March 2017, capex is expected to drop to £5.7bn, in line with Vodafone’s long-term historical level of 13% to 14% of revenue.

However, the forecast 18% boost to earnings provided by the return to normal capex still leaves it trading on a sky-high price-to-earnings (P/E) ratio of 38, compared with the FTSE 100 long-term forward average of around 14. Vodafone’s price-to-earnings growth (PEG) ratio is also unattractive at 2.1. On the PEG scale, growth at a reasonable price is represented by a number below 1, so Vodafone’s PEG of 2.1 suggests investors are paying over the odds.

Should you invest £1,000 in AstraZeneca right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca made the list?

See the 6 stocks

Heavy exposure to the eurozone is also a concern. We might have expected last year’s European Central Bank stimulus to feed through to improving analyst earnings forecasts for Vodafone for 2016/17. In fact, City number-crunchers have been reducing their forecasts. The macro outlook for Europe remains fragile and Vodafone earnings forecasts could continue to trend lower. Of course, the effect of that would be to push the P/E and PEG even higher… unless the share price falls to compensate.

Finally, converged services (combinations of fixed line, broadband, public Wifi, TV and mobile) are increasingly looking like the future, and Vodafone is behind the curve on the infrastructure and content to provide them. Management is onto this – an asset swap with Liberty Global was discussed last year – but becoming a major player in converged services is a big challenge. Furthermore, while Vodafone’s dividend is attractive (the forecast yield is 5.2%), a mega-merger/acquisition could lead to a rethink on the dividend policy.

There are many more appealingly valued companies with more certain outlooks, so I’m avoiding it, for now.

Stanley Gibbons

AIM-listed stamps and collectibles group Stanley Gibbons is a company I’ve never been very keen on. The stuff it deals in has little “intrinsic value”, so a rising market value depends largely on the “greater fool theory” – stamp buyers believe others will be willing to pay an even higher price in the future. Even if we concede that stamps and suchlike have some appeal as an “alternative asset class”, investing in the business isn’t the same as investing in the asset class.

In August 2008, as the financial crisis was snowballing, Stanley Gibbons crowed: “The benefits of investing in collectibles as an alternative asset class have never been clearer … [Prices] show no correlation with the stock market … a safe haven in difficult economic conditions”.

However, its shares didn’t provide a safe haven. The company issued a profit warning five months later as management deferred the booking of some sales originally slated for 2008 to 2009. Those sales didn’t materialise and there was a further profit warning in January 2010.

The position is similar today, with the company having warned on profits in October, “as a result of the weakness being experienced in our Asian operations and the continued illiquidity in high value stock items”. The share price has collapsed, putting Stanley Gibbons on a seemingly bargain single-digit P/E. However, I’m not prepared to bet against there being a further profit warning during 2016/17, so this is another stock I’m avoiding.

But what does the head of The Motley Fool’s investing team think?

Should you invest £1,000 in AstraZeneca right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

Down 64%, this FTSE 250 stock offers a 13% dividend yield for investors

This struggling investment banker has suffered significant losses in the past five years, but it has the second-highest yield on…

Read more »

Investing Articles

1 stock market ETF I’ve been buying during the sell-off

The stock market's been all over the place in April, creating a fertile breeding ground for long-term buying opportunities.

Read more »

Investing Articles

As the Sainsbury share price bucks the price-war trend on FY results, I examine the dividend prospects

The J Sainsbury share price has been regaining ground, despite growing fears of intense competition in the supermarket sector.

Read more »

The words "what's your plan for retirement" written on chalkboard on pavement somewhere in London
Investing Articles

Should I invest in a Stocks and Shares ISA or a SIPP to retire early?

Early retirement is the ultimate goal for many investors, but choosing between a Stocks and Shares ISA and a pension…

Read more »

Investing Articles

Is now a great time to consider buying Greggs shares?

Greggs shares have been hammered in 2025. But have they now fallen too far? Paul Summers takes another look at…

Read more »

Investing Articles

Is it still a great time to buy cheap shares as stock market crash fears recede?

Fear of a stock market crash can trigger panic selling... but that surely can't be the best thing to do…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

The Vodafone share price is 24% undervalued, according to analysts

Our writer’s been looking at the latest targets for the Vodafone share price. Although there’s a wide variation, the average…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I think there’s 1 big surprise in this broker’s top 10 FTSE ‘mid-cap’ growth stocks!

Our writer’s been looking at the 10 favourite FTSE stocks of one particular investment bank. But he’s not impressed by…

Read more »